VDC test kit slider

Study suggests vitamin D deficiency impairs the effectiveness of non-Hodgkin lymphoma treatment

Posted on: August 23, 2014   by  Will Hunter


Research from Journal of Clinical Oncology found that vitamin D deficiency may impair the efficacy of treatment and outcome of patients with diffuse large B-cell lymphoma.

Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma, a cancer that affects a type of white blood cell known as a lymphocyte. The specific type of lymphocyte that DLBCL affects is B cells, which serve to make antibodies to fight against pathogens.

A common treatment for DLBCL includes the use of a synthetic antibody called rituximab that destroys B cells, both normal and malignant. This process is called rituximab-mediated cellular cytotoxicity.

You must be a paid member to read the rest of this post. Please login or register now.

Test Your Vitamin D Levels at Home!

Our in-home vitamin D test kit is easy, affordable, and an accurate way to find out your Vitamin D status.

order NOW

We need your help!

We're spreading awareness on Vitamin D Deficiency
Donate NOW
Latest Articles
What is the relationship between vitamin D and childhood UTIs?

A new study suggests vitamin D may protect against UTIs among children by upregulating their own naturally occurring antimicrobial peptides.

Weekly Newsletter

Our Sponsors

December 21st is DDAY. Click here to celebrate the day with us!